We review the emergence of the new field of organ-on-a-chip (OOAC) engineering, from the
parent fields of tissue engineering and microfluidics. We place into perspective the tools and …

Adipose‐derived stem cells (ASCs) are a mesenchymal stem cell source with properties of
self‐renewal and multipotential differentiation. Compared to bone marrow‐derived stem …

Tissue engineering has emerged at the intersection of numerous disciplines to meet a
global clinical need for technologies to promote the regeneration of functional living tissues …

Background: Over recent decades, scientists and surgeons have collaborated to develop
various bioengineered and synthetic products as an alternative to skin grafts. Despite the …

The ultimate goal of regenerative medicine is to repair, regenerate, or reconstruct functional
loss in failed tissues and/or organs. Although regenerative medicine is a relatively new field …

Cell and protein arrays have demonstrated remarkable utility in the high-throughput
evaluation of biological responses; however, they lack the complexity of native tissue and …

This report presents a detailed update to our 2008 publication on the tissue engineering
(TE) and stem cell industry. Data are reported through mid 2011 showing an almost three …

Bioreactor technology is vital for tissue engineering. Usually, bioreactors are used to provide
a tissue‐specific physiological in vitro environment during tissue maturation. In addition to …

Abstract Development of human skin substitutes by tissue engineering may offer new
therapeutic alternatives to the use of autologous tissue grafts. For that reason, it is necessary …

Spinal cord injury (SCI) is a devastating health condition that may lead to permanent
disabilities and death. Understanding the pathophysiological perspectives of traumatic SCI …